Early weight loss with liraglutide 3.0 mg is a good predictor of clinically meaningful weight loss after 56 weeks

被引：0
|
作者：
Le Roux, Carel [1 ]
Bluher, Matthias [2 ]
Hermansen, Kjeld [3 ]
Greenway, Frank [4 ]
Fujioka, Ken [5 ]
Donsmark, Morten [6 ]
Jensen, Christine [6 ]
Wilding, John [7 ]
机构：
[1] Univ Coll Dublin, Dublin, Ireland
[2] Univ Leipzig, Leipzig, Germany
[3] Aarhus Univ Hosp, Aarhus, Denmark
[4] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA
[5] Scripps Clin, La Jolla, CA 92037 USA
[6] Novo Nordisk AS, Soborg, Denmark
[7] Univ Liverpool, Liverpool, Merseyside, England
来源：
BRITISH JOURNAL OF SURGERY | 2017年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
E06
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [1] Early weight loss with liraglutide 3.0 mg is good predictor of clinically meaningful weight loss after 56 weeks
    Blueher, M.
    Hermansen, K.
    Greenway, F.
    Fujioka, K.
    Donsmark, M.
    Jensen, C. B.
    Wilding, J. P. H.
    DIABETOLOGIA, 2015, 58 : S310 - S310
  • [2] Early weight loss with liraglutide 3.0 mg is a good predictor of clinically meaningful weight loss after 56 weeks
    Wilding, J. P. H.
    Hermansen, K.
    Greenway, F.
    Fujioka, K.
    Donsmark, M.
    Nzeakor, N.
    Blueher, M.
    DIABETIC MEDICINE, 2016, 33 : 83 - 83
  • [3] Liraglutide 3 mg for Weight Loss in a Real-World Setting: Clinical Outcomes after 56 Weeks
    Buckley, Adam J.
    Suliman, Mohamed
    Al Tikriti, Alia
    Lessan, Nader
    Le Roux, Carel
    Tan, Tricia M.
    Barakat, Maha T.
    DIABETES, 2019, 68
  • [4] Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers
    Fujioka, Ken
    O'Neil, Patrick M.
    Davies, Melanie
    Greenway, Frank
    Lau, David C. W.
    Claudius, Birgitte
    Skjoth, Trine Vang
    Jensen, Christine Bjorn
    Wilding, John P. H.
    OBESITY, 2016, 24 (11) : 2278 - 2288
  • [5] Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
    Muratori, Fabrizio
    Vignati, F.
    Di Sacco, G.
    Gavazzi, L.
    Pellegrino, D.
    Del Prete, M.
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2022, 27 (07) : 2775 - 2781
  • [6] Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
    Fabrizio Muratori
    F. Vignati
    G. Di Sacco
    L. Gavazzi
    D. Pellegrino
    M. Del Prete
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2022, 27 : 2775 - 2781
  • [7] Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects
    Bays, Harold
    Pi-Sunyer, Xavier
    Hemmingsson, Joanna Udden
    Claudius, Birgitte
    Jensen, Christine B.
    Van Gaal, Luc
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (02) : 225 - 229
  • [8] Early weight loss as a predictor of 3-year weight loss and weight regain in patients with good compliance after sleeve gastrectomy
    Yang, Po-Jen
    Chen, Chi-Ling
    Chen, Chiung-Nien
    Lin, Ming-Tsan
    Wang, Weu
    SURGERY FOR OBESITY AND RELATED DISEASES, 2021, 17 (08) : 1418 - 1423
  • [9] Comment on: Early weight loss as a predictor of 3-year weight loss and weight regain in patients with good compliance after sleeve gastrectomy
    Lo Menzo, Emanuele
    SURGERY FOR OBESITY AND RELATED DISEASES, 2021, 17 (08) : 1423 - 1424
  • [10] Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery
    Wharton, Sean
    Kuk, Jennifer L.
    Luszczynski, Magdalena
    Kamran, Elham
    Christensen, Rebecca A. G.
    CLINICAL OBESITY, 2019, 9 (04)
12345